(jofem.org) The best-case signal: modest weight loss in a shorter trial A frequently cited 12-week randomized trial result (as summarized in reviews) reported: ~2.6 kg average loss with AOD-9604 1 mg/day vs ~0.8 kg with placebo (PMC) This is the kind of result that can be statistically meaningful, clinically modest, and very sensitive to study design (diet, activity, baseline metabolic status, adherence)
The injectable route through compounded tirzepatide is especially valuable for this group
Follow-up Repeat metabolic markers after 8-12 weeks if the protocol is being continued or adjusted
The lipo shots increase your energy levels quite quickly, which allows the fat loss to be seen almost immediately, when this is combined with exercise and a healthy diet, you can see noticeable results in as little as 30 days
The experiment included detailed clinical, morphological, and histological assessments to determine the degree of joint degeneration and recovery following different intra-articular treatments [1]